EVALUATION OF SPIRAMYCIN AS A THERAPEUTIC AGENT FOR ELIMINATION OF NASOPHARYNGEAL PATHOGENS - POSSIBLE USE OF SPIRAMYCIN FOR MIDDLE-EAR INFECTIONS AND FOR GONOCOCCAL AND MENINGOCOCCAL NASOPHARYNGEAL CARRIAGE

被引：33

作者：

KAMME, C

KAHLMETER, G

MELANDER, A

机构：

[1] UNIV LUND HOSP,DEPT MED MICROBIOL,S-22185 LUND,SWEDEN

[2] UNIV LUND HOSP,DEPT CLIN PHARMACOL,S-22185 LUND,SWEDEN

来源：

关键词：

D O I：

10.3109/inf.1978.10.issue-2.07

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：135 / 142

页数：8

共 26 条

[21]

SOUS H, 1964, ZAHNARZTL WELT, V65, P523

[22] MICROBIOLOGY OF MIDDLE EAR AND NASOPHARYNX [J].

SPRINKLE, PM ;

VELTRI, RW .

[23] SECRETORY OTITIS MEDIA - IMMUNE-COMPLEX DISEASE [J].

VELTRI, RW ;

SPRINKLE, PM .

WEIDMER, CE ;

DUNKEL, TB ;

PETTYJOHN, FS ;

SMITH, CD ;

LEIBOVITZ, A .

[25] SPIRAMYCIN EXCRETION IN ANIMALS .1. SINGLE ORAL DOSE IN RATS [J].

YANKELL, SL ;

LEUNG, FC ;

GARDNER, JM ;

PAOR, WS .

[26]

1974, LANCET, V1, P1431